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Abstract
Rhinacanthus nasutus (R. nasutus) leaf extract was prepared and standardized to obtain rhinacanthins rich extract
that contained total rhinacanthin-C (Rn-C) of not less than 70% w/w. Rn-C was also isolated from the standardized R. nasutus
leaf  extract  (SRLE).  SRLE  was  investigated  on  pain  and  inflammatory  models  in  parallel  with  its  main  naphthoquinone
constituent, Rn-C in order to compare their efficacy in experimental animals. The analgesic activities of SRLE and Rn-C were
evaluated by the acetic acid-induced writhing test, a hot-plate test and formalin test at doses of 20, 40, and 80 mg/kg. The
anti-inflammatory activities were investigated by carrageenan induced paw edema and the cotton pellet induced granuloma
in rats at doses of 80, 160, and 320 mg/kg. SRLE and Rn-C inhibited the acetic acid induced writhing in a dose dependent
manner; inhibited the early phase of the formalin test at 80 mg/kg and the late phase at 40 and 80 mg/kg. However, none of
the tested doses were effective in protecting against the hot plate test. In the animal models of inflammation, SRLE and Rn-C
dose dependently inhibited edema formation in the carrageenan induced paw edema and suppressed granuloma formation in
the cotton pellet induced granuloma in rats. The effects of SRLE in these tests were similar to those of the Rn-C. This study
confirms the analgesic and anti-inflammatory activities of SRLE and Rn-C in animal models as well as demonstrating that they
have a similar efficacy.
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1. Introduction
Rhinacanthus nasutus (Linn.) Kurz (Acanthaceae) is a
small shrub widely distributed and cultivated in India, China,
Taiwan, and in Southeast Asia including Thailand (Siripong
et al., 2006). Different parts of this plant have long been used
in  traditional  medicine  for  the  treatment  of  a  variety  of
ailments. In Thailand, the leaves are used as an antipyretic,
anti-inflammatory, antihypertensive, antisnake venom and as
a detoxicant (Farnsworth and Bunyapraphatsara, 1992). In
India, the leaves and roots of the plant are widely used for
the treatment of rheumatism (Cheruvathur et al., 2012).
Although, several groups of compounds like flavo-
noids, anthraquinones, triterpenes and steroids have been
identified in extracts from the plant, naphthoquinones are
reported to be the most biologically active constituent (Sendl
et  al.,  1996).  Among  several  naphthoquinone  analogues
identified, Rn-C is found to be the major naphthoquinone in
the leaf extract (Panichayupakaranant et al., 2009) and has
shown several pharmacological activities. Rn-C has shown
potent antiviral activity (Sendl et al., 1996), cytotoxicity (Wu
et al., 1998), antiproliferative (Siripong et al., 2006), anti-
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inflammatory (Tewtrakul et al., 2009a) and antiallergic (Tew-
trakul et al., 2009b) activities. Recently, a rhinacanthins-rich
R. nasutus  leaf  extract  that  contained  a  total  amount  of
rhinacanthins  of  not  less  than  70%  showed  antifungal
(Panichayupakaranant et al., 2009) as well as antibacterial
(Puttarak et al., 2010) activities with a potency similar to that
of Rn-C.
Despite the evidence from the reports of the various
aforementioned  biological  activities,  analgesic  and  anti-
inflammatory activities of the standardized R. nasutus leaf
extract (SRLE), standardized to contain total rhinacanthin-C
of not less than 70% w/w, and its main active compound,
Rn-C, have not been explored in any animal model. Therefore,
this study was designed to evaluate the analgesic and anti-
inflammatory activities of SRLE in parallel with Rn-C, the
major active constituent, in order to compare their efficacy
in experimental animals.
2. Materials and Methods
2.1 Chemicals and reagents
Indomethacin was obtained from Fluka BioChemika,
Japan;  morphine  sulphate  and  carrageenan  lambda  were
from Sigma (St. Louis, U.S.A.); acetic acid was from J.T. Baker
Inc.  U.S.A.;  propylene  glycol  and  formalin  were  from
Vidhyasom Co., Ltd., Thailand; tween-80 was from Srichand
United Dispensary Co., Ltd., Thailand. All other chemicals
and solvents used in this study for extraction of plant material
and quantitative analysis were of reagent or HPLC grade. Test
compounds and indomethacin were dissolved in a cosolvent
consisted of propylene glycol, tween 80 and distilled water
(4:1:4)  with  the  exception  of  morphine  sulfate  that  was
dissolved  in  normal  saline.  All  were  prepared  just  before
commencing the experiment.
2.2 Plant material
Fresh leaves of R. nasutus were collected from the
botanical garden of the Faculty of Pharmaceutical Sciences,
Prince  of  Songkla  University,  Thailand,  in  June  2011.
A voucher specimen (No. 0011814) was identified by Dr. P.
Panichayupakaranant (Department of Pharmacognosy and
Pharmaceutical Botany, Faculty of Pharmaceutical Sciences,
Prince of Songkla University, Thailand), and deposited at the
herbarium of the Faculty of Pharmaceutical Sciences, Prince
of Songkla University, Thailand. The collected leaves were
dried in a hot air oven at 50°C for 24 hrs and grounded into a
fine powder.
2.3 Preparation of crude extract
The powdered material (2.0 kg) was macerated with
8 L of 95% ethyl acetate at room temperature for three days
with  frequent  stirring.  After  three  days,  the  macerate  was
filtered and evaporated to obtain a syrupy mass. The marc
was remacerated again with ethyl acetate four times, filtered,
and evaporated until it became a thick viscous mass (160 g).
2.4 Preparation of standardized R. nasutus leaf extract
Rhinacanthins rich extract was prepared from the
crude extract according to the method previously described
(Panichayupakaranant et al., 2009). The crude ethyl acetate
extract (135 g) was dissolved in methanol, filtered and loaded
to  a  column  packed  with  Amberlite®  IRA-67  (Sigma,  St.
Louis, U.S.A.). The solution was allowed to drain from the
lower  valve  of  column  at  a  flow  rate  of  1.5  mL/min.  The
column was then washed with methanol to remove chloro-
phyll. The rhinacanthins that remained in the column was
then eluted with 10% acetic acid in methanol. The collected
solution was evaporated under reduced pressure to give the
rhinacanthins rich extract (48 g).
Quantitative  analysis  of  the  Rn-C  content  in  the
rhinacanthins rich extract was then performed by the reverse-
phase high performance liquid chromatographic method
using  a  TSK-gel  ODS-80Ts  column  (Tosoh  Bioscience,
Tokyo, Japan). The mobile phase consisted of methanol and
5% aqueous acetic acid (80:20, v/v) pumped at a flow rate of
1 mL/min. The injection volume was 20 ìL. The quantification
wavelength was set at 254 nm. The SRLE thus obtained with
an Rn-C content of not less than 70% w/w was used for the
isolation of pure Rn-C as well as for further animal experi-
ments.
2.5 Isolation of rhinacanthin-C
The SRLE obtained was chromatographed over silica
gel  using  hexane  and  ethyl  acetate  (99:1)  as  the  solvent
system to obtain pure Rn-C. The first fraction obtained from
the silica gel column was again chromatographed through a
silica gel column using the same solvent system to remove
any remaining interfering compounds and further purify Rn-
C. The pure Rn-C thus obtained was elucidated by 
1H NMR
spectral data. The compound was verified by comparing the
1H NMR  spectral  data  obtained  with  those  previously
reported (Sendl et al., 1996).
2.6 Animals
Animals used in this study were male ICR mice weigh-
ing 25-35 g and male Wistar rats weighing 150-200 g. They
were obtained from the Southern Laboratory Animal Facility,
Prince of Songkla University, Hat Yai, Thailand. The animals
were housed in standard cages for at least one week in the
laboratory animal room prior to testing. Food and water were
given ad libitum unless otherwise specified. All experimental
protocols were approved by the Animal Ethics Committee,
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2.7 Analgesic activities
2.7.1  Writhing test
An acetic acid-induced writhing test was carried out
according to the method described previously (Koster et al.,
1959). Male ICR mice were divided into eight groups with ten
animals each. Different groups were orally administered with
cosolvent (10 mL/kg), indomethacin (5 mg/kg), SRLE and
Rn-C (20, 40, and 80 mg/kg), respectively. After 30 min, 0.6%
acetic acid solution (10 mL/kg) was injected into the perito-
neal cavity and the number of writhing episodes was counted
for 20 min. A reduction in the writhing number compared to
the control group was evaluated for analgesia which was
expressed as the percentage inhibition of writhings.
2.7.2  Hot plate test
The hot plate test was carried out according to the
method previously described (Woolfe and Macdonald, 1944).
Male  ICR  mice  were  divided  into  nine  groups  with  ten
animals in each group. Different groups were administered
with cosolvent (10 mL/kg), indomethacin (5 mg/kg), morphine
sulfate (5 mg/kg, s.c.), SRLE and Rn-C (20, 40, and 80 mg/kg),
respectively. Thirty minutes after oral administration of the
test  agents,  or  15  min  after  subcutaneous  injection  of
morphine sulphate, the nociceptive response was measured
every 15 min over a 60 min period by individually placing
each mouse on a hot plate (Harvard Apparatus Ltd., UK)
maintained at a constant temperature of 55°C ± 1°C. Latency
of the nociceptive response such as licking of a hind limb or
jumping was noted. The cut-off time was fixed at 45 sec to
prevent tissue damage. Only the mice that showed a nocicep-
tive response within 15 sec were used in the experiments.
2.7.3  Formalin test
The formalin test was performed as previously reported
(Hunskaar et al., 1985). Male ICR mice were divided into nine
groups with ten animals in each group. Different groups were
administered with cosolvent (10 mL/kg), indomethacin (5 mg/
kg), morphine sulfate (5 mg/kg, s.c.), SRLE and Rn-C (20, 40,
and 80 mg/kg), respectively. Thirty minutes after oral adminis-
tration of the test agents, or 15 minutes after subcutaneous
injection  of  morphine  sulfate,  20  µL  of  2.5%  formalin  in
normal saline solution was injected subcutaneously to a right
hind paw of each mouse. The time spent by each mouse on
licking  the  injected  paw  was  recorded.  The  data  were
expressed as the total licking time in the early phase (0-5 min)
and the late phase (15-30 min) after formalin injection.
2.8 Anti-inflammatory activities
2.8.1  Carrageenan-induced rat paw edema
The acute anti-inflammatory activity was evaluated
by carrageenan-induced rat paw edema model as previously
described (Winter et al., 1962). Male Wistar rats were divided
into eight groups with six animals in each group. The initial
volume of right hind paw of each rat was measured using a
plethysmometer (Ugobasile, Milan, Italy). Different groups
of rats were orally administered with cosolvent (5 mL/kg),
indomethacin (5 mg/kg), SRLE and Rn-C (80, 160, and 320
mg/kg), respectively. After 30 minutes, each rat of every
group was subcutaneously injected with 0.1 mL of 1% (w/v)
carrageenan in normal saline into the subplantar region of
the  right  hind  paw.  The  volume  of  right  hind  paw  was
measured at 1, 3 and 5 h after carrageenan injection, and the
edema volume was determined.
2.8.2  Cotton pellet-induced granuloma in rats
The cotton pellet-induced granuloma was performed
according to the technique previously described (Swingle
and Shideman, 1972). Male Wistar rats were divided into
eight groups with six animals in each group. The rats of each
group were orally administered with cosolvent (5 mL/kg),
indomethacin (5 mg/kg), SRLE and Rn-C (80, 160,  and 320
mg/kg), respectively. After 20 min, the rats were anesthetized
and sterile cotton pellets weighing 20±1mg each were asepti-
cally implanted in both sides of the groin regions by making
small subcutaneous incisions. The incisions were sutured.
The respective doses were administered once daily for seven
consecutive days. On the 8
th day, the animals were sacrificed
and the pellets were removed carefully and dried in a hot air
oven at 60°C until the weight became constant. The mean
weight of the granuloma tissue formed around each pellet
was recorded. The weight of the pellets removed from the
test groups were compared with those removed from the
control group. Inhibition of granuloma was evaluated for
the  anti-inflammatory  activity  that  was  expressed  as  a
percentage inhibition of granuloma.
2.9 Statistical analysis
Data obtained are expressed as a mean±S.E.M. and
were evaluated by one-way ANOVA followed by Dunnett’s
test. A significant difference is considered at p<0.05.
3. Results
3.1 Effects of SRLE and Rn-C on nociceptive responses in
mice
3.1.1  Writhing test
Oral administration of SRLE and Rn-C significantly
decreased the number of writhings produced by intraperito-
neal administration of 0.6% acetic acid in a dose-dependent
manner as shown in Figure 1. Both the SRLE and Rn-C at
the dose of 80 mg/kg produced an inhibitory effect with a
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were  comparable  to  69.51%  inhibition  produced  by  the
standard drug indomethacin (5 mg/kg).
3.1.2  Hot plate test
In the hot plate test, none of the test substances at
any of the tested doses produced significant effect, but the
opioid analgesic morphine sulphate (5 mg/kg) significantly
increased the latency of nociceptive response (Table 1).
3.1.3  Formalin test
As shown in Figure 2, oral administration of SRLE
and  Rn-C  at  the  doses  of  40  and  80  mg/kg significantly
(p<0.05) decreased the licking time in the late phase but only
the higher dose of 80 mg/kg of both the SRLE and Rn-C sig-
nificantly decreased the licking time in the early phase. The
percentage inhibition of SRLE at doses of 40 and 80 mg/kg
in the late phase was 22.81 and 67.57% and  that of Rn-C (40
and 80 mg/kg) was 28.62 and 74.37%, respectively. In the
early  phase,  the  SRLE  and  Rn-C  at  dose  of  80  mg/kg
produced 37.18 and 46.86% inhibition. The standard drug,
indomethacin, exhibited a significant effect only on the late
Figure 1. Effect of SRLE, Rn-C and indomethacin on 0.6% acetic
acid-induced writhing in mice. Doses are expressed as
mg/kg. Data are presented as a mean ± S.E.M. (n=10).
The number above each column denotes the inhibition
percentage. *p<0.05, significantly different compared with
the control (Dunnett’s test).  Cntl = Control,  Indo =
Indomethacin.
Table 1. Effect of SRLE, Rn-C, indomethacin and morphine on heat-induced pain in mice.
        Latency of nociceptive response (sec)
   Treatment
30 min 45 min 60 min 75 min 90 min
Control - 11.30 ± 0.56 11.67 ± 0.58 11.37 ± 0.44 10.71 ± 0.37 9.60 ± 0.63
Indomethacin 5 12.28 ± 0.82 12.75 ± 0.97 11.87 ± 0.56 12.28 ± 1.02 10.44 ± 0.92
Morphine 5 18.03 ± 0.96* 19.48 ± 1.11* 22.44 ± 1.67* 22.55 ± 1.09* 21.12 ± 1.26*
SRLE 20 10.73 ± 0.59 12.27 ± 0.80 11.76 ± 0.84 12.24 ± 0.82 11.16 ± 0.80
40 11.93 ± 0.72 12.26 ± 0.76 11.99 ± 0.89 11.20 ± 0.78 12.48 ± 0.90
80 12.55 ± 0.77 12.34 ± 0.65 12.48 ± 0.71 12.65 ± 0.66 10.81 ± 1.08
Rn-C 20 10.19 ± 0.96 10.52 ± 1.01 12.07 ± 1.35 11.72 ± 0.89 10.78 ± 1.07
40 10.68 ± 0.62 10.79 ± 0.50 11.38 ± 0.85 10.61 ± 0.93 9.66 ± 1.05
80 10.73 ± 0.59 11.56 ± 0.71 11.18 ± 0.73 11.47 ± 1.33 9.06 ± 0.74
* p<0.05, significantly different compared with the control (Dunnett’s test).
Values are presented as a mean ± S.E.M (n=10).
Dose
(mg/kg)
Figure 2. Effect of SRLE, Rn-C, indomethacin and morphine on
the early phase (A) and the late phase (B) of formalin-
induced paw licking in mice. Doses are expressed  as mg/
kg. Data are presented as a mean ± S.E.M. (n=10). The
number above each column denotes the inhibition per-
centage. * p<0.05, significantly different compared with
the control (Dunnett’s test).  Cntl = Control,  Indo =
Indomethacin, Morp = Morphine.329 N. Bhusal et al. / Songklanakarin J. Sci. Technol. 36 (3), 325-331, 2014
phase  (59.91%  inhibition)  whereas  morphine  sulfate
decreased  the  licking  time  both  in  the  early  and  the  late
phases (60.32 and 74.05% inhibition). The result showed that
the  effects  of  the  SRLE  and  Rn-C  at  dose  of  80  mg/kg,
indomethacin (5 mg/kg) and morphine sulphate (5 mg/kg)
were comparable to each other in the late phase of formalin
test.
3.2 Effects of SRLE and Rn-C on inflammations in rats
3.2.1  Carrageenan-induced paw edema
Figure 3 shows the results of the carrageenan-induced
rat paw edema. The volume of the carrageenan injected paw
increased progressively and reached a maximum after three
hours in the control group, whereas in the SRLE and Rn-C
treated groups, both exhibited a significant inhibition of paw
edema induced by carrageenan in a dose dependent manner.
SRLE and Rn-C at the dose of 320 mg/kg produced 54.69 and
60.94% inhibition of edema that was comparable to 59.38%
inhibition produced by the standard drug indomethacin (5
mg/kg) at 5 hrs of carrageenan injection.
3.2.2  Cotton pellet-induced granuloma
Both, the SRLE and Rn-C at doses of 80, 160, and 320
mg/kg significantly decreased the granuloma weight (Table
2) although their activity was a little lower than that of the
standard drug indomethacin (5 mg/kg). SRLE at the dose of
80 mg/kg produced 18.22% inhibition of granuloma, Rn-C
at the same dose produced 17.81% and the standard drug
indomethacin, produced 24.29% inhibition of granuloma.
4. Discussion
In the present study, both SRLE and Rn-C showed
analgesic as well as acute and chronic anti-inflammatory
activities in the animal models with a similar efficacy. The
acetic acid-induced writhing test is the most common method
for screening potential analgesic activity. Intraperitoneal
administration of acetic acid produces a nociceptive response
consisting of a wave of constriction and elongation that
passes caudally along the abdominal wall followed by exten-
sion of the hind limbs (Collier et al., 1968). Nociception is
produced by the direct activation of peritoneal nociceptors
(Julius  and  Basbaum,  2001)  as  well  as  by  the  release  of
prostaglandins (Deraedt et al., 1980) which play an important
role in inflammatory pain. In the present study, both SRLE
and Rn-C at the dose of 80 mg/kg exhibited the suppression
of acetic acid-induced writhing with the magnitude compa-
rable to the standard drug indomethacin indicating their
antinociceptive activity.
Further investigation of analgesic activity was done
by  a  hot  plate  test  as  this  can  distinguish  between  the
centrally acting analgesic drugs from the peripherally acting
Figure 3. Effect of SRLE, Rn-C and indomethacin on carrageenan-
induced paw edema in rats. Data are presented as a
mean ± S.E.M. (n=6). * p<0.05, significantly different
compared with the control (Dunnett’s test).
Table 2. Effect of SRLE, Rn-C and indomethacin on cotton pellet-induced granuloma
formation in rats.
 Treatment Dose Granuloma weight Granuloma weight GI
(mg/kg) (mg) (mg/mg cotton) (%)
Control - 49.31 ± 0.44 2.47 ± 0.02 -
Indomethacin 5 37.48 ± 1.32* 1.87 ± 0.07* 24.29
SRLE 80 40.95 ± 0.59* 2.05 ± 0.03* 17.00
160 40.83 ± 0.66* 2.04 ± 0.03* 17.41
320 40.37 ± 0.50* 2.02 ± 0.02* 18.22
Rn-C 80 41.90 ± 1.05* 2.10 ± 0.05* 14.98
160 41.43 ± 0.32* 2.07 ± 0.02* 16.19
320 40.61 ± 0.91* 2.03 ± 0.05* 17.81
*p<0.05 significantly different from the control (ANOVA followed by Dunnett’s test).
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analgesic drugs. Pain induced by the heat can be alleviated
by a centrally acting narcotic analgesics (Janicki and Libich,
1979) whereas peripherally acting drugs will be ineffective
(Vogel, 2002). In our experiment, all the tested doses of both
SRLE and Rn-C showed no significant effect in the hot plate
test so this precluded the involvement of opioid receptors in
their analgesic activity. Morphine sulfate (opioid analgesic)
on  the  other  hand  significantly  delayed  the  nociceptive
response in the test whereas indomethacin was ineffective
in inhibiting the nociceptive response.
The formalin test was performed in order to further
understand the mechanism of analgesic effect. The formalin
test has two phases, (1) an early phase (0-5 min) of short-
lasting nociception (neurogenic pain) is caused by direct
stimulation of nociceptors with the chemical irritant, while (2)
the late phase (15-30 min) of tonic pain (inflammatory pain)
is due to the release of inflammatory mediators and changes
in the central processing (Tjølsen et al., 1992). Substance P
and bradykinin are responsible for the early phase while
inflammatory mediators like histamine, serotonin, prostaglan-
dins and bradykinin are involved in the late phase (Shibata
et al., 1989). Centrally acting drugs can inhibit both phases
however, peripherally acting drugs like most of the NSAIDs
inhibit only the second phase (Hunskaar and Hole, 1987).
In this study, as SRLE and Rn-C at their higher tested dose
(80 mg/kg) significantly inhibited the nociceptive response
in the early phase as well as late phase while the moderate
dose (40 mg/kg) inhibited only the late phase. This indicated
the involvement of a central effect depending on the dose
although both were more effective in the inflammatory pain.
On the other hand, indomethacin was effective only in the
late phase.
In the present study, carrageenan induced rat paw
edema was selected as an acute model of inflammation. It is a
suitable animal model for evaluation of an anti-inflammatory
activity  of  a  new  compound  (Vinegar  et  al.,  1969).  The
response induced by injection of carrageenan involves three
phases each is attributed to different chemical mediators. The
initial phase of 1.5 hrs is caused by the release of histamine
and serotonin followed by the second phase from 1.5 to 2.5
hrs that is mediated by kinins, and the third phase occurs
from 2.5 to 6 hrs and is presumably mediated by prostaglan-
dins  (Di  Rosa,  1972).  In  this  test,  both  SRLE  and  Rn-C
produced a significant inhibitory effect on edema formation
in a dose dependant manner. This effect was significant from
the first measurement and was maintained throughout the
study  period  of  five  hours.  This  indicated  that  the  anti-
inflammatory mechanism of action of the tested compounds
may  be  through  the  inhibition  of  early  mediators  like
histamine  and  serotonin  as  well  as  the  products  of  the
prostaglandin  biosynthesis  pathway.  These  results  also
corroborated  the  previous  report  that  Rn-C  inhibits  the
prostaglandin E2 and the nitric oxide release by inhibiting the
gene  expression  of  COX-2  and  the  inducible  nitric  oxide
synthase (Tewtrakul et al., 2009a).
SRLE  and  Rn-C  also  significantly  inhibited  the
granuloma formation in the cotton pellet-induced granuloma
test. This is an established model for studying the efficacy
of compounds in the chronic inflammation. Proliferation of
macrophages,  neutrophils  and  fibroblasts  are  the  basic
sources of granuloma formation (Li et al., 2008). Therefore,
inhibition  of  granuloma  formation  by  SRLE  and  Rn-C
indicates the suppression of the proliferative phase of the
inflammatory  response.  The  efficacy  of  SRLE  and  Rn-C
against both the carrageenan induced edema and the cotton
pellet  induced  granuloma  indicated  that  they  are  active
against both the exudative and the proliferative phases of
the inflammatory response.
From the findings of our study, it is evident that Rn-C,
the major active constituent, is responsible for the analgesic
and anti-inflammatory activities of SRLE. However, as the
activities of SRLE in all experimental models were compar-
able to Rn-C, it might be possible that its activity is amplified
by the synergistic activity with other rhinacanthins such as
rhinacanthin-D and -N (Puttarak et al., 2010) presented in the
SRLE, which have also shown anti-inflammatory activities
in an in vitro experiment (Tewtrakul et al., 2009a). Therefore,
SRLE is superior over Rn-C in terms of cost effectiveness
and time.
From  these  investigations,  it  was  concluded  that
SRLE and Rn-C both have analgesic and anti-inflammatory
activities. The analgesic activity of these substances may be
mediated through central and peripheral mechanism depend-
ing  on  the  dose.  Their  anti-inflammatory  activity  can  be
attributed at least to the inhibition of prostaglandin synthe-
sis. Moreover, the most important finding of these investiga-
tions is that the efficacy of both SRLE and Rn-C were similar
in analgesic and anti-inflammatory activities. This reinforces
SRLE as a potential phytomedicine for pain and inflammatory
conditions.
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